Table 1.
Clinicopathologic correlation of supervillin expression in human HCC
| Clinical Pathological Parameters | n | SVIL | Χ2 | P |
|---|---|---|---|---|
| Gender | ||||
| Male | 132 | 94(71.2%) | 0.06 | >0.05 |
| Female | 41 | 30(73.2%) | ||
| Age (Years) | ||||
| ≥ 45 | 118 | 83(70.3%) | 0.33 | >0.05 |
| <45 | 55 | 41(74.5%) | ||
| AFP (ng/L) | ||||
| ≤ 200 | 23 | 13(56.5%) | 3.11 | >0.05 |
| >200 | 57 | 20(35.1%) | ||
| Tumor Size (cm) | ||||
| ≤ 3 | 24 | 12(50.0%) | 1.14 | >0.05 |
| >3~ 10 | 41 | 15(36.6%) | ||
| >10 | 15 | 6(40.0%) | ||
| Grade of Differentiation | ||||
| Well-differentiated | 18 | 13(72.2%) | 0.07 | >0.05 |
| Moderately-differentiated | 110 | 77(70.0%) | ||
| Poorly-differentiated | 39 | 28(71.2%) | ||
| Portal Vein Tumor Thrombus | ||||
| Yes | 33 | 30(91.0%) | 15.44 | <0.01 |
| NO | 40 | 19(47.5%) | ||
| Serosal Infiltration | ||||
| Yes | 35 | 28(80.0%) | 12.64 | <0.01 |
| NO | 30 | 11(36.7%) | ||
| Distant Metastasis | ||||
| Yes | 29 | 23(80.6%) | 9.79 | <0.01 |
| NO | 20 | 7(35.0%) | ||